| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JCP.25071 |
| P8608 | Fatcat ID | release_3lj6cshqwbgbrop26bfxjly6ie |
| P698 | PubMed publication ID | 26058815 |
| P2093 | author name string | Andrew J Carr | |
| Pierre-Alexis Mouthuy | |||
| Edward T Stace | |||
| Stephanie G Dakin | |||
| P2860 | cites work | Control of stem cell fate by physical interactions with the extracellular matrix | Q24648041 |
| Platelet-rich plasma therapy - future or trend? | Q26859723 | ||
| Matrix elasticity directs stem cell lineage specification | Q27860761 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q28111913 | ||
| A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned | Q28242411 | ||
| Medical device recalls and the FDA approval process | Q28305384 | ||
| Tissue engineering | Q29617288 | ||
| Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration | Q29619618 | ||
| The pandemic of physical inactivity: global action for public health | Q30419494 | ||
| The effect of substrate topography on direct reprogramming of fibroblasts to induced neurons | Q33623601 | ||
| Trials and fast changing technologies: the case for tracker studies | Q33807132 | ||
| Communicating data about the benefits and harms of treatment: a randomized trial | Q33964865 | ||
| The determination of stem cell fate by 3D scaffold structures through the control of cell shape | Q34010641 | ||
| Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells | Q34062087 | ||
| An evaluation of internal-mammary-artery ligation by a double-blind technic | Q34246261 | ||
| Steps toward safe cell therapy using induced pluripotent stem cells | Q34325607 | ||
| Regenerative medicine: the emergence of an industry | Q34333327 | ||
| Restore orthobiologic implant: not recommended for augmentation of rotator cuff repairs | Q51033137 | ||
| Early inflammatory reaction after rotator cuff repair with a porcine small intestine submucosal implant: a report of 4 cases. | Q51503788 | ||
| The challenge of immunogenicity in the quest for induced pluripotency. | Q51776242 | ||
| Moving medicine forward faster. | Q52869058 | ||
| Translating cell-based regenerative medicines from research to successful products: challenges and solutions. | Q53091015 | ||
| The regulatory imperative: international perspective. | Q53119628 | ||
| Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases. | Q53512200 | ||
| Delivering affordable cancer care in high-income countries | Q56994721 | ||
| Electrospinning: processing technique for tissue engineering scaffolding | Q57171681 | ||
| The CSAW Study (Can Shoulder Arthroscopy Work?) - a placebo-controlled surgical intervention trial assessing the clinical and cost effectiveness of arthroscopic subacromial decompression for shoulder pain: study protocol for a randomised controlled t | Q57447121 | ||
| The burden of musculoskeletal conditions | Q57751070 | ||
| Biophysical regulation of epigenetic state and cell reprogramming | Q34378901 | ||
| Ethical and social considerations of stem cell research | Q34426507 | ||
| The systematic production of cells for cell therapies | Q34861981 | ||
| Strong evidence against platelet-rich plasma injections for chronic lateral epicondylar tendinopathy: a systematic review | Q35101031 | ||
| Enabling consistency in pluripotent stem cell-derived products for research and development and clinical applications through material standards. | Q35119693 | ||
| Perspectives of evidence-based surgery | Q35128149 | ||
| Tissue engineered constructs: perspectives on clinical translation | Q35386959 | ||
| Scaffold translation: barriers between concept and clinic | Q35570019 | ||
| Trials in surgery | Q35625965 | ||
| Key factors in the rising cost of new drug discovery and development | Q35770173 | ||
| Egg harvesting for stem cell research: medical risks and ethical problems | Q36606365 | ||
| IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage | Q36937308 | ||
| IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages | Q36937313 | ||
| IDEAL framework for surgical innovation 1: the idea and development stages | Q36937320 | ||
| The challenges faced in the design, conduct and analysis of surgical randomised controlled trials | Q37126288 | ||
| The promise of human induced pluripotent stem cells for research and therapy | Q37242440 | ||
| Scaffolds for tendon and ligament repair: review of the efficacy of commercial products | Q37357355 | ||
| The developmental roles of the extracellular matrix: beyond structure to regulation. | Q37626596 | ||
| Use and efficacy of bone morphogenetic proteins in fracture healing. | Q37893542 | ||
| A hitchhiker's guide to mechanobiology | Q37901782 | ||
| The need to address the burden of musculoskeletal conditions | Q38026114 | ||
| Controlling self-renewal and differentiation of stem cells via mechanical cues. | Q38054708 | ||
| Designing regenerative biomaterial therapies for the clinic. | Q38059838 | ||
| Engineering in vitro microenvironments for cell based therapies and drug discovery. | Q38117522 | ||
| The anatomy of medical research: US and international comparisons | Q38317057 | ||
| Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial | Q38376404 | ||
| Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics | Q39275085 | ||
| Acellular biomaterials: an evolving alternative to cell-based therapies. | Q40153139 | ||
| The biomechanical and histologic effects of platelet-rich plasma on rat rotator cuff repairs | Q40434658 | ||
| An efficient and safe xeno-free cryopreservation method for the storage of human embryonic stem cells | Q40485637 | ||
| Quantification of DNA in biologic scaffold materials. | Q42114909 | ||
| Porcine small intestine submucosa augmentation of surgical repair of chronic two-tendon rotator cuff tears. A randomized, controlled trial | Q42687574 | ||
| Commercialization of regenerative medicine: learning from spin-outs | Q43729948 | ||
| The stroma as a crucial target in rat mammary gland carcinogenesis | Q44783994 | ||
| One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial. | Q44981526 | ||
| Porcine small intestine submucosa (SIS) is not an acellular collagenous matrix and contains porcine DNA: possible implications in human implantation | Q45286600 | ||
| A brief definition of regenerative medicine | Q48012344 | ||
| Nanogrooved substrate promotes direct lineage reprogramming of fibroblasts to functional induced dopaminergic neurons | Q48338735 | ||
| Ethical issues in the design of randomized trials: to sham or not to sham | Q48409643 | ||
| Autologous tenocyte therapy using porcine-derived bioscaffolds for massive rotator cuff defect in rabbits | Q50992477 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 36-49 | |
| P577 | publication date | 2015-06-09 | |
| P1433 | published in | Journal of Cellular Physiology | Q1524270 |
| P1476 | title | Translating Regenerative Biomaterials Into Clinical Practice | |
| P478 | volume | 231 |
| Q92600821 | Biomaterials to Mimic and Heal Connective Tissues |
| Q38788701 | Regenerative pharmacology: recent developments and future perspectives |
| Q38656661 | Synthetic sutures: Clinical evaluation and future developments |
| Q89112289 | [Regeneration - A New Therapeutic Dimension in Otorhinolaryngology] |
Search more.